C12N 2710/20042
Virus or viral particle as vehicle
Official title: virus or viral particle as vehicle, e.g. encapsulating small organic molecule
C12N2710/20042 (Virus or viral particle as vehicle) appears on 5 US grants and 11 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 11
- Assignees
- 11
- Inventors
- 19
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 2 |
| 2021 | 0 | 2 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 1 | 2 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for treating bladder tumors with viral nanoparticle conjugates and immune checkpoint inhibitors31 Mar 2026US 12,589,165 B2Aura Biosciences, Inc.
- Probe for universal detection of circulating tumor cells21 Jan 2025US 12,203,935 B2University of Houston System
- Non-human papillomaviruses for gene delivery in vitro and in vivo2 Apr 2024US 11,946,048 B2Angewandten Forschung E.V.
- Papovavirus pseudocapsids and use thereof for exogenous material transfer2 Sep 2003US 6,613,749 B1Imperial College Innovations Limited
- Polyoma virus pseudocapsids and method to deliver material into cell4 Apr 2000US 6,046,173 ACaduceus Limited
- Probe for universal detection of circulating tumor cells29 May 2025US 2025/0172561 A1
- Probe for universal detection of circulating tumor cells22 May 2025US 2025/0164490 A1
- Compositions, Methods and Systems for the Delivery of Gene Editing Material to Cells9 Feb 2023US 2023/0045095 A1Massachusetts Institute of Technology
- Targeted combination therapy19 May 2022US 2022/0152217 A9Aura Biosciences, Inc.
- Targeted combination therapy23 Sep 2021US 2021/0290778 A1Aura Biosciences, Inc.
Most cited
By later US patents